FDA Inspection 1297464 — LGC Clinical Diagnostics, Inc.
The FDA completed an inspection of LGC Clinical Diagnostics, Inc. on Dec 10, 2025 in Milford, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 10, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Milford, MA (United States)